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Introduction
The Special Programme for Research and Training in Trop-
ical Diseases, based at and executed by the World Health
Organization (WHO), states that these maladies affect mil-
lions of people across the world [1–5]. They are more
common in tropical and subtropical regions, as in temperate
climates the cold season is able to control the insects pop-
ulation, which are the most common disease carriers or
vectors. The flies and mosquitos may carry parasites, bacte-
ria or viruses that can infect humans and animals through a
“bite”, which transmits the illness agent through a sub-
cutaneous blood exchange. Some factors like deforestation,
exploration of tropical areas, and increasing international air
travel to tropical regions lead to an increase of tropical
diseases. For some of them, unfortunately, vaccines are still
not available.
The recent explosive growth of nanogold applications
in many areas [6–9], also comprises contributions to the
health field [10–14]. In particular, gold can have a
direct role in treatment and detection of tropical dis-
eases, as shown by some studies found in literature.
Besides some examples of molecular gold used directly
against parasites and in research dealing with animal
parasitic diseases [15–17], gold nanoparticles and gold
complexes can also play a significant role that goes
beyond the classical approach of confirmation diagnosis,
based on detection of parasites in either blood or lymph
by microscopy, as it will be explained below.
Trypanosomiases
About the diseases
There are two different types of human trypanosomiases [1, 2]:
the humanAfrican trypanosomiasis and the American trypano-
somiasis. The latter is more studied, but it is important to also
refer the progresses made so far on the former.
The human African trypanosomiasis, also known as
“sleeping sickness”, is a well-known tropical disease, caused
by the protozoan parasites Trypanosoma brucei rhodesiense
or Trypanosoma brucei gambiense. It is spread by a bite of an
infected tsetse fly, which erupts into a red sore. Within a few
weeks, it causes fever, swollen lymph glands, aching muscles
and joints, headaches and irritability. In advanced stages, the
disease attacks the central nervous system, causing changes in
personality, alteration of the circadian rhythm, confusion,
slurred speech, seizures, and difficulty walking or talking.
These problems can develop over many years in the
gambiense form and some months in the rhodesiense form.
If not treated, it can cause death. An early diagnosis is of
extreme importance for a better control of this sickness.
The American trypanosomiasis, or Chagas disease, is caused
by the protozoan parasite Trypanosoma cruzi, generically sche-
matized in Fig. 1. It is found mainly in Latin America, where it
is mostly transmitted to humans by the faeces of triatomine
bugs [2]. This disease can cause death from myocarditis or
meningoencephallitis during its acute phase, in less than 5–
10%of symptomatic cases. The evolution for the chronic phase
(10–30 years after infection) can result in cardiac, digestive
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(megaesophagus and megacolon), or cardiodigestive problems
in 30–40 % of the infected patients [18].
Microscopy assays using nanogold
In 1997, Magez et al. [19], knowing that the protozoan
Trypanosoma brucei is lysed by the cytokine tumor necrosis
factor-α (TNF-α), prepared TNF-α gold nanoparticles
(TNF-α-AuNP) using commercial 10 nm gold beads. These
TNF-α-AuNP were endocytosed via coated pits and vesi-
cles and are directed towards lysosome-like digestive organ-
elles. The localization of TNF-α binding sites on intact
parasites and a better understanding of intracellular uptake
of TNF-α were possible precisely with the help of the
conjugated colloidal gold particles. The bulk of the TNF-α
gold labeling was localized in the flagellar pocket, where
beads concentrated in coated pits. Sporadically, TNF-α-
AuNP were found in association with the flagellum in the
flagellar adhesion zone, at the entrance of the flagellar
pocket, or in association with tiny filamentous material at
more distant regions of the flagellum.
Soeiro et al. [20] performed ultrastructural analysis of the
endocytic process (cellular uptake) using horseradish peroxi-
dase (HRP) enzyme coupled to colloidal gold particles (HRP-
AuNP). The "in vitro" findings suggest that cardiomyocytes
(cells of cardiac muscle) mannose receptors, localized at the
sarcolemma (muscle cell membrane), mediate T. cruzi recog-
nition and can be down-modulated by parasite infection.
Okuda and co-workers [21] used ultrathin sections of
T. cruzi epimastigote forms. These assays, which reveal gold
particles at the opening of flagellar pocket, concentrated in the
cytostome region, were possible through immunogold label-
ing (a staining technique used in electron microscopy, where
colloidal gold nanoparticles are usually attached to secondary
antibodies, which are attached to primary antibodies designed
to bind a specific protein or other cell component). The
protocol consists in cytoskeletons incubation in the first anti-
body, which recognizes the cytoskeletons elements; then in-
cubated in the second antibody, which recognizes the first
antibody and have attached a 15 nm gold particle. Using
electron microscopy to visualize the gold nanoparticles
(AuNP), and consequently the known proximity of the ele-
ments recognized by the antibody–antibody–AuNP configu-
ration, the relationship between the cytostome, an endocytic
organelle, and the flagellum was described for the first lime.
Gold has high electron density which increases electron scat-
ter enabling high contrast images.
A similar protocol allowed Monteiro et al. [22], in 2001,
to describe the localization of chagasin, an endogenous
tight-binding cysteine protease inhibitor in T. cruzi. Gold-
labeled antibodies localized chagasin to the flagellar pocket
and cytoplasmic vesicles of trypomastigotes and to the cell
surface of amastigotes (the former are found in human blood
and the later in tissues). Thin sections were incubated with
affinity purified rabbit anti-chagasin followed by gold-
conjugated goat anti-rabbit Immunoglobulin G (IgG).
Silva et al. [23] evaluated the presence and distribution of
the Ssp4 antigen in the different amastigote T. Cruzi
populations using gold-labeled antibodies, allowing the ob-
servation with transmission electron microscopy. Goat anti-
mouse IgG was labeled with 10 nm gold particles. These
were mainly located inside cytoplasmic vesicles and the
flagellar pocket, suggesting that Ssp4 is released by exocy-
tosis into the flagellar pocket.
Recently, Acosta et al. [24] used immunogold electron
microscopy analysis for providing a new insight to better
understand the molecular pathogenesis of Chagas heart dis-
ease. They showed that there is a common epitope between
cruzipain (a lysosomal major antigen from T. cruzi) and either
myosin or other cardiac O-linked N-acetylglucosamine
containing proteins.
Eger and Soares [25] described the visualization by confocal
microscopy of ingested gold (15 nm) labeled transferrin in
epimastigote forms of the protozoan T. cruzi. This is a promis-
ing imaging tool to explore the endocytic pathway in trypano-
somes (and eventually adapted for other protozoans).
Detection methods using gold
In 2003, Diniz et al. [26], prepared a gold electrode for
adsorbing a polypeptide chain formed by recombinant anti-
gens: cytoplasmic repetitive antigen (CRA) and flagellar
repetitive antigen (FRA) of T. cruzi. The goal was to devel-
op a biosensor for Chagas disease, based on impedance
spectroscopy, with the behavior of CRA/FRA antigens
adsorbed on gold and platinum electrodes being investigat-
ed. The team also used platinum electrodes, which yielded
similar results as those presented by gold; however, the
marked influence of oxygen dissolved in solution on the
electrochemical response of platinum, requires extensive
deoxygenation of solutions prior each experiment. Conse-
quently, gold electrodes have advantages. Under proper
conditions, it is possible to distinguish between serum pos-
itive and negative to Chagas disease.
Fig. 1 Trypanosoma cruzi cell schematic representation (adapted from
[87, 88]). a Nucleus, b flagellar pocket, c flagellum, d cytostome, e
cytoplasmic vesicles, f cytoskeleton
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Joining the last two methods (as an “immunotechnique”
is applied, but gold acts as a supporting electrode for
sensing purposes, instead of labeling), Ferreira et al. [27]
immobilized Chagas disease antigens in a gold surface, and
the anti-T. cruzi antibodies present in the serum sample were
captured by the antigen, remaining connected to the solid
phase. The human anti-IgG antibody conjugated to peroxidase
(HRP) then reacted with immunocaptured anti-T. cruzi anti-
bodies, if any present. The detection and quantification was
ensured by peroxidase activity in presence of H2O2 and, in the
presence of the iodide, this ion reacted with the reduced
peroxidase. Under these conditions, the current intensity of
I2 reduction was proportional to the amount of anti-T. cruzi
antibodies in the serum real sample. This assembling is sche-
matized in Fig. 2.
In a very similar approach, Ribone and co-workers [28]
prepared bioelectrodes to detect IgG antibodies occurring in
sera of patients suffering from American trypanosomiasis.
The main difference from the previous description [27], is
the use of two different thiols, 3-mercapto-1-propionic acid
(MPA), 3-mercapto-1-propanesulfonic acid (MPSA), which
provide sulfonate or carboxylic residues, for the electrostatic
binding of the antigen. Figure 2 also applies to the assem-
bling described in this work, where the linkage to the gold
electrode is described generically as “thiol”.
Foguel et al. [29] used the same principle for the con-
struction of an amperometric imunosensor. The novelty here
was the gold based electrode being obtained from a record-
able compact disc (CD-R), then modif ied with
4-(methylmercapto)benzaldehyde for the immobilization of
Tc85 protein of the T. cruzi. To access the metal layer of the
CD-R, concentrated HNO3 was added on the surface and
after 5–10 min the protective layers were totally removed. It
is well known that organic monolayers with thiol or
disulfide groups on the electrode surface are of great
interest due to the sulfur binding strongly to the gold
surface. A molecule that presents this property is
4-(methylmercapto)benzaldehyde (SBZA), which has a
mercapto group and maintains a free aldehydic group.
In order to link the CD-R fragment and allow the amperomet-
ric process, a laminated copper wire was fixed and insulated
with polytetrafluoroethylene (PTFE), so that the wire does not
come into contact with the electrolyte solution, thus avoiding
the oxidation and reduction of this copper.
Using a similar methodology, a microfluidic system
coupled to a screen-printed carbon electrode (SPCE)
was developed by Pereira and co-workers [30] for the
quantitative determination of IgG specific antibodies
present in serum samples of patients with Chagas dis-
ease. This time, HRP in the presence of H2O2 catalysed
the oxidation of 4-tert-butylcatechol (4-TBC) and its
back electrochemical reduction was detected on a mod-
ified electrode. The authors claimed that, compared with
traditional IgG detection techniques, the immunosensor
based on microfluidic technology showed a decrease in
sample and reagent consumption, faster response times
for analysis, and good reproducibility and did not re-
quire highly skilled technicians or expensive and dedi-
cated equipment.
Deborggraeve et al. [31] developed a simple and rapid
test for detection of amplified T. brucei DNA, the human
African trypanosomiasis–polymerase chain reaction–
oligochromatography (HAT–PCR–OC). In this case, gold
was used essentially as a colorimetric indicator. PCR prod-
ucts were visualized on a dipstick through hybridization
with a gold-conjugated probe (oligochromatography), oc-
curring in 5 min. The lower detection limit of the test was
5 fg of pure T. brucei DNA; one parasite in 180 μl of blood
is still detectable. The authors concluded that HAT–PCR–
OC is a promising new tool for diagnosis of “sleeping
sickness” in laboratory settings.
Nanogold chemoterapy
Nyarko et al. [32] described the effects of aqueous Au(III) and
his metalloporphyrin derivative on T. brucei brucei growth in
culture. While Au(III) porphyrin was effective against the par-
asites at concentrations above 4.8×10−6M, aqueous Au(III) ion
was toxic to the trypanosomes at concentrations as low as 2.0×
10−7 M, due to free radicals formation. Although the parasite
tested is responsible for an animal African trypanosomiasis
(and this review deals mainly with human tropical diseases),
the work of Nyarko et al. shows that gold might have a
promising role in the battle against these noxious organisms.
A series of seven papers regarding metal-based chemother-
apy against tropical diseases was published by Sánchez-
Delgado and co-workers [33–39], from 1993 to 2004.
Navarro, who wrote a very interesting review in 2009 about
Fig. 2 Immunosensors supported on a gold electrode (adapted from
[29, 30])
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gold complexes as potential anti-parasitic agents [40], pub-
lished since 1997, together with different co-workers, also
some papers in this series [35, 36, 38, 39]. In one of those
publications [36], the authors dealt with a group of metal–
clotrimazole complexes evaluating their activity against
T. cruzi, including AuCl3(clotrimazole). The clotrimazole
(CTZ) is an azole derivative, and this family of compounds
has been developed as chemotherapeutic agents for the treat-
ment of fungal diseases on the basis of their properties as
sterol biosynthesis inhibitors, which can also affect some
parasites [36]. This AuCl3(CTZ) complex (Fig. 3, middle)
showed an anti-T. cruzi epomastigotes activity only slightly
higher than the free CTZ (60 % vs. 58 %), with a poor
performance compared other metal–CTZ complexes [36,
40]. In another paper [38], Navarro et al. considered other
azol derivative (ketoconazole [KTZ]) and other Au precursor,
preparing [Au(CTZ)(PPh3)]PF6 (Fig. 3, top) and
[Au(KTZ)(PPh3)]PF6⋅2H2O (Fig. 3, bottom) complexes. Both
complexes (1μM) showed an inhibition of the proliferation
of the T. cruzi epimastigotes around 70 %, while the
free CTZ has no effect on the growth and KTZ only
inhibited 39 % at the same concentration [38, 40].
It is also important to mention the role of gold in biolistic
(or biological ballistics, consisting in transfecting cells by
bombarding them with microprojectiles coated with DNA)
immunization using a stable DNA–gold precipitate [41]. As
the target population of a T. cruzi vaccine lives predomi-
nately in poorer rural areas in South America, the use of
such DNA–gold precipitate, which does not require a cold
chain, is an attractive method for vaccination.
Leishmaniasis
About the disease
Some Leishmania parasitic protozoa are the cause of leish-
maniasis in humans. The disease is spread through the bite
of phlebotomine sandflies, which breed in forest areas,
caves and adobe brick houses, where most of the transmis-
sion to humans takes place. This disease can be divided in
four main types [3]:
(1) Cutaneous forms, with skin ulcers usually on exposed
areas, such as the face, arms and legs, that usually heal
within a few months, but leaving scars.
(2) Diffuse cutaneous leishmaniasis, which produce dissem-
inated and chronic skin lesions and it is difficult to treat.
(3) Mucocutaneous forms, where the lesions can destroy
the mucous membranes of the nose, mouth, throat
cavities and surrounding tissues.
(4) Visceral leishmaniasis (VL), which is characterized
by high fever, considerable weight loss, anemia,
spleen and liver swelling. If not treated, the disease
can have a fatality rate, as high as 100 %, within
2 years.
Fig. 3 AuI-clotrimazole (1), AuIII-clotrimazole (2) and AuI-ketocona-
zole (3) complexes (adapted from [40], counterions omitted for
simplification)
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Microscopy assays using nanogold
Santos et al. [42], in 1991, used transmission electron
microscopy for observation of lectins associated with
colloidal gold particles (15 nm). AuNP bound to con-
canavalin A (a lecitin protein) were found randomly and
sparsely distributed on the Leishmania donovani chagasi
surface, along the cell body and along the flagellum.
The pre-treatment of promastigotes of with trypsin did
not interfere with the binding of lectins to the parasite
or alter the parasite ultrastructure, showing a good re-
sistance to this protease. However, a pre-treatment with
2-mercaptoethanol increased the colloidal gold density,
showing that this last compound exposed second-order
concanavalin A receptors.
The intracellular fate of human transferrin (HTf) in
macrophages infected by Leishmania was investigated
by Borges et al. [43], i.e., binding the HTf to gold
nanoparticles complexes for further observation in order
to understand the location and processing of HTf across
time. Within parasites, HTf was found in cysteine-
proteinase-rich structures, suggesting that the protein
can be endocytosed by intracellular amastigotes and
sorted to the parasite endosomal–lysosomal compart-
ments rather than being recycled.
Sengupta et al. [44] explored the relation between
hemoglobin endocytosis and the parasite, using
immunogold techniques, contributing to understand the
hemoglobin destruction, a critical aspect in the disease.
A specific high affinity binding site on the surface of
Leishmania donovani promastigotes mediated rapid in-
ternalization and degradation of hemoglobin. When
Leishmania, previously incubated with hemoglobin at
4 °C, were treated with a rabbit anti-hemoglobin anti-
body, followed by an anti-rabbit IgG conjugated with
colloidal gold, accumulation of gold particles could be
seen in the flagellar pocket. After incubation with he-
moglobin–gold conjugates at 25 °C or 37 °C, the par-
ticles accumulated in discrete intracellular vesicles,
suggesting the internalization of hemoglobin at both
temperatures. Quantitation could be carried out by
counting the number of gold particles internalized by
Leishmania for each set of experimental conditions.
Detection methods using nanogold
Zijlstra et al. [45] evaluated a strip test employing recombi-
nant K39 (rK39) antigen and protein-A (a surface protein
originally found in the cell wall of the bacterium Staphylococ-
cus aureus)/colloidal gold as read-out agents. They stated that
this test has the ideal format for use in the field but also has
important limitations and should be used with caution. In
general, a positive test result in a patient who presents with
the classical clinical features of VL supports the diagnosis. It
should be noted that a positive test result may be the result of
previous (subclinical) infection and therefore not relevant to
the current illness. Under field conditions, it is not always clear
from the history whether a patient who reports previous treat-
ment for VLwas correctly diagnosed at the time. Such test was
used recently by Carreira et al. [46] in order to study the natural
infection with Leishmania infantum on opossums (Didelphis
aurita), considered natural hosts of parasites, suggesting their
important role in the epidemiology of VL. This work allowed
the authors to present the first report of amastigotes in the
tissues of Didelphis aurita naturally infected with L. infantum.
Ramos-Jesus and co-workers [47] prepared a quartz crys-
tal gold electrode where the recombinant antigen of Leish-
mania chagasi rLci2B-NH6 was tightly immobilized on a
quartz crystal gold electrode by self-assembled monolayer
based on short-chain length thiol. This device was planned
for the canine visceral form; however this assembling seems
to be promising also for human leishmaniasis. It is important
to distinguish from the similar examples given before [27,
28], as no immunotechnique is applied to sensor construc-
tion in this case. The amine groups of cysteamine provided
reaction sites for covalently bind to the glutaraldehyde. The
rLci2B-NH6 antigen was then immobilized through a Schiff
base via glutaraldehyde by a histidine tail (Fig. 4). The
Schiff base allows major exposure of epitopes and a reduced
steric hindrance. The response was obtained by recognition
of immobilized rLci2B-NH6 antigen.
Moreno et al. [48] designed a novel SELEX procedure (a
methodology in which single stranded oligonucleotides are
selected from a wide variety of sequences based on their
interaction with a target molecule) using colloidal gold to
select high affinity single stranded DNA aptamers that bind
specifically to L. infantum KMP-11. Kinetoplastid mem-
brane protein-11 (KMP-11) is a major component of the cell
Fig. 4 Quartz crystal gold electrode supporting rLci3B-NH6 via cyste-
amine and glutaraldehyde (adapted from [47]). Glycine presence repre-
sents the blocking treatment in order to minimize the nonspecific binding
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membrane of kinetoplastid parasites. Although its function
is not known, the fact that KMP-11 is a cytoskeleton-
associated protein suggests that it may be involved in mo-
bility or in some other aspects of the flagellar structure. The
method is based on the binding of the target protein to
colloidal gold in order to achieve a higher amount of that
protein for further purification by centrifugation. This novel
methodology is very easy to use and cheaper than others that
are currently being used. The same authors also developed an
electrochemical biosensor based on aptamers that can recognize
and specifically report the presence of L. infantumKMP-11. The
target protein was conjugated with gold nanoparticles and the
complexes electrodeposited on gold screen-printed electrodes
(SPE) [49]. Using this method, Moreno et al. were able to detect
25 mg/ml of KMP-11.
Nanogold chemotherapy and thermotherapy
Recently, Ilari et al. [50] reported on the interesting
antiparasitic actions of a well-known antiarthritic agent,
the gold(I)-containing drug Auranofin. As trypanothione
reductase, a key enzyme of L. infantum, contains a dithiol
motif at its active site and gold(I) compounds are known to
be highly thiophilic, it was found that Auranofin behaved as
an effective enzyme inhibitor. It might also be a potential
antileishmanial agent, as it was also found that Auranofin is
able to kill the promastigote stage of L. infantum at micro-
molar concentration. These important findings will certainly
contribute to the design of new drugs against this disease.
Navarro et al. [51] studied a gold complex prepared from
a dypirido[3,2-a: 2,3-c]phenazine ligand, [Au(dppz)2]Cl3
(Fig. 5), that interacts with DNA by intercalation mode.
The large leishmanicidal activity of this complex was asso-
ciated to the cellular processes involving parasite DNA,
constituting a new promising chemotherapeutic alternative
in the search for the cure of leishmaniasis [51].
More recently, Barboza-Filho et al. [52] studied the
growth of Leishmania brasiliensis promastigotes in culture,
using natural rubber membranes with and without gold
nanoparticles. It was observed that the increase of
AuNP caused a decrease in the number of promastigotes
in culture medium. These results are advanced as a
possible solution for developing a flexible “band-aid”
for skin lesions, inhibiting the population growth of parasites
in the lesions.
A recent study from Sazgarnia et al. [53] determined
the efficacy of thermotherapy in the presence of AuNP
and microwave radiation (2,450 MHz) on the survival
of Leishmania major promastigotes and amastigotes. It
was shown that the presence of AuNP during micro-
wave irradiation (after cell incubation) was more lethal
for promastigotes and amastigotes when compared to
microwave radiation alone. This shows that AuNP are
a promising new approach to treat leishmaniasis in the
future.
Malaria
About the disease
Malaria is caused by the Plasmodium parasite, which is
transmitted through the bites of infected mosquitos. After
entering in the human body, the parasites multiply in the
liver and infect the red blood cells. Fever, headache, and
vomiting are symptoms of malaria and usually appear be-
tween 10 and 15 days after the mosquito bite. Malaria can
quickly become life-threatening by disrupting the blood
supply to vital organs and, in many parts of the world, the
parasites have developed resistance to a number of known
medicines. About 3.3 billion people (almost half of the
world's population) are at risk of getting malaria. Every
year, this leads to about 250 million cases and nearly 1
million deaths. Consequently, a prompt and effective treat-
ment is crucial [4].
Microscopy assays using nanogold
In the study performed by Bhowmick et al. [54],
immunogold electron microscopy was used for sub-cellular
localization of Plasmodium falciparum enolase. This protein
was detected at every stage of the parasite life cycle, in
cytosol (the liquid found inside cells) and associated with
nucleus, food vacuole (storage membrane bound organelle),
cytoskeleton and plasma membrane. Diverse localization of
enolase suggests that apart from catalysing the conversion of
2-phosphoglyceric acid into phosphoenolpyruvate in glycol-
ysis (its typical role in cytosol), it may also be involved in
other functions, namely, in red blood cell invasion, food
vacuole formation and/or development and transcription.
These new data seems to clarify the role of this enzyme in
the parasite life.
The work of Chugh et al. [55], helped to determine the
reasons why two monoclonal antibodies (AC-43 and AC-
Fig. 5 Complex prepared by Navarro et al. from dypirido[3,2-a: 2,3-c]
phenazine ligands (perpendicular to each other) (adapted from [51])
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29) significantly inhibited Plasmodium vivax development
inside the mosquito Anopheles culicifacies midgut (a por-
tion of insect's digestive system). The gold labeling showed
that these two monoclonal antibodies bind to glycoproteins
present in the gut epithelium (intestine wall), a known zone
for its ookinetes receptors (receptors of the fertilized zygote
of the parasite in the mosquito's body), which assures the
crossing of the epithelial barrier and provide components for
further development into oocysts (the encysted or encapsu-
lated ookinetes in the mosquito's inside). These data point to
these glycoproteins as potential candidates for a vector-
directed transmission-blocking vaccine, stopping the para-
site cycle in the ookinetes–oocysts transition step.
Recently, Lopes da Silva et al. [56] used bovine serum
albumin (BSA) linked to 10 nm AuNP in order to follow
their position in the parasite–host cell system, in the liver
stage, a crucial phase of the Plasmodium development. The
authors showed that when BSA-Au are loaded into the host
cell endocytic pathway, the AuNP are later found within the
parasite cytoplasm, showing the transport of materials from
the host endocytic pathway towards the parasite interior,
revealing a possible form of the parasite to obtain nutrients.
Detection methods using nanogold
Stevens et al. [57] described a different approach using AuNP.
The Immunoglobulin M (IgM) antibody bounded to the assay
membrane acts as the capture molecule. The gold–antibody
conjugate acts as the label, generating a visible increase in
optical density proportional to the concentration of analyte
present, that is, the malarial antigen P. falciparum histidine-
rich protein II (PfHRP2). If this antigen (which acts as a bridge
between the membrane–IgM and Au–IgG systems) is not
present, Au–IgG will disappear after washing and no changes
in optical density will be observed. A positive test is schema-
tized in Fig. 6.
Amperometric immunosensors can also be used for mon-
itoring this disease. Sharma et al. [58] presented recently a
sensor based on AuNP/alumina sol–gel modified SPE for
antibodies to PfHRP2. The AuNP electrode (AuNP/Al2O3
sol–gel/SPE) had much larger amperometric current
(390 nA) than the bare SPE (120 nA) and Al2O3 sol–
gel/SPE (154 nA). AuNPs/Al2O3 sol–gel/SPE was three
times more sensitive compared to unmodified/bare SPE for
the same concentration of analyte. Recently, Fu et al. [59]
developed a device consisting on a two-dimensional paper
network signal-amplified immunoassay for malaria protein
PfHRP2 detection. The paper card contains reagents stored
in dry form, including an antibody conjugated to a gold
particle label, and the user only needs to add water and the
sample. Factors like the signal/noise ratio and test sensitivity
are always a concern with AuNP based (and other) tests.
Therefore, improvements in this area are also important,
besides the test principle itself, as demonstrated for the
PfHRP2 malaria biomarker [60].
Potipitak et al. [61] created a device specifically for
P. falciparum that can be adapted for other parasites. A
biotinylated probe was linked to the gold electrode of
quartz crystal microbalance (QCM) surface based on the
specific interaction between avidin protein and biotin
(vitamin B7). Prior to this immobilization, the QCM
surface was pre-treated (e.g., with MPA) to add the
ester group on the surface, in order to bind with the
amine group of avidin. This technique was based on DNA
piezoelectric biosensor using the Au electrode of QCM. The
deposited mass, due to DNA hybridization on the QCM
surface, resulted in a shift of the quartz resonance frequency.
Moreover, the new sensor is cost-effective since both sides of
the quartz Au surface can be used separately, reducing the
sensor price to 50 %.
Very recently, Guirgis et al. [62] described a homo-
geneous assay based on the fluorescence quenching of
cyanine 3B (Cy3B)-labeled recombinant P. falciparum
heat shock protein 70 (PfHsp70) upon binding to AuNP
functionalized with an anti-Hsp70 monoclonal antibody.
Upon competition with the free antigen, the Cy3B-
labeled recombinant PfHsp70 is released to solution
resulting in an increase of fluorescence intensity. Concerning
test kits involving colloidal gold, Piper et al. [63] re-
cently showed that a panel of monoclonal antibodies
against Plasmodium lactate dehydrogenase can be used
in various combinations to uniquely identify all species
of malaria parasites that infect humans. Their results
should help the development of new test with greater
specificity, sensitivity and ability to differentiate among
malaria parasite species, adding to some solutions al-
ready in the market [64].
Nanogold chemoterapy
Concerning antimalarial gold compounds, and in context of
the already mentioned series of seven papers related to
metal-based chemotherapy against tropical diseases
[33–39], Navarro et al. described the reaction of AuPPh3Cl
with chloroquine (CQ) and KPF6 leading to the newFig. 6 PfHRP2 positive assay (adapted from [57])
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complex [Au(PPh3)(CQ)]PF6. This compound was found to
be considerably more active than CQ diphosphate and other
previously reported metal–CQ complexes (Ru or Rh [34])
against two chloroquine-resistant strains of P. falciparum in
vitro [35]. Navarro et al. also prepared a series of new Au(I)
and Au(III) complexes containing CQ in combination with
other ligands, which display activity against CQ-sensitive
but also against CQ-resistant strains of P. falciparum [39].
The highest activity for this series was obtained for
[Au(CQ)(PEt3)]PF6. More recently, Navarro et al. [65] stud-
ied the mechanism of antimalarial action of [Au(CQ)(PPh3)]
PF6. This compound seems to avoid heme aggregation
(which allows accumulation of toxic levels of compound,
resulting in parasite death). The high activities observed
against parasites resistant to chloroquine are probably due
to the structural modification of CQ introduced by the
presence of the gold-triphenylphosphine fragment. The
scheme of these complexes can be found in Fig. 7.
Blackie et al. [66] described the synthesis of [Au(R)(PPh3)]
NO3 and [Au(C6F5)(R)] complexes, where R denotes a CQ
group or a ferrocenyl-4-amino-7-chloroquinoline, and their
use as anti-malarial agents. Rh complexes were also tested.
The CQ complexes showed better efficacy against CQ-
resistant strains of the P. falciparum when comparing to free
CQ. For the CQ-resistant strain, there is a considerable drop in
efficacy. Concerning to the compounds with the ferrocenyl-4-
amino-7-chloroquinolines, those containing ferroquine
were considered the most efficient, but all showed im-
proved efficacy with respect to CQ in both sensitive and
resistant strains.
Fricker et al. [67] used a set of six Au(III) complexes,
showing that all of them were able to inhibit cathepsin B,
with a half maximal inhibitory concentration (IC50) values
in the range of 0.2–1.4 μM. Cysteine proteases cathepsin B
play multiple roles in the parasite life cycle like nutrition,
host invasion, protein processing, and evasion of the host
immune response, so their inhibition can be extremely
important.
Also well-known gold-based drugs like Auranofin (the
antiarthritic medicine that also demonstrated potential
antileishmanial activity, as referred above), showed recently
very pronounced antiplasmodial effects in vitro [68].
Auranofin proved to be a potent inhibitor of mammalian
thioredoxin reductases causing severe intracellular oxidative
stress. Given the high sensitivity of P. falciparum to oxidative
stress, the authors thought that Auranofin might act as an
effective antimalarial agent and showed that this compound
(and a few other related gold complexes) strongly inhibits P.
falciparum growth in vitro.
Recently, Bjelosevic et al. [69] prepared a set of gold(I)
complexes based on 1,10-bis(diphenylphosphino) metallocene
derivatives (Fig. 8) and evaluated their activity against malaria
(W2 chloroquine-resistant strain of P. falciparum) and other
diseases. Although the IC50 values (half-maximal inhibitory
concentrations, which indicate how much are needed to induce
inhibitions of 50 %) are low, they are still much higher than
those for chloroquine. The biological activities of ruthenocenyl-
based gold compounds are superior to their ferrocenyl ana-
logues and thus provide directions as to which of these ligands
can be used for medicinal applications.
Very recently, Hemmert et al. [70] described the use of
gold(I) and gold(III) complexes with N-heterocyclic carbene
(NHC) ligands as antimalarial agents, specifically against
the chloroquine-resistant P. falciparum strain FcM29-
Cameroon. A group of four dinuclear gold(I) complexes
plus three dinuclear gold(III) complexes (Fig. 9, top) was
studied, followed by another group of three mononuclear
gold(I) complexes (Fig. 9, bottom). The gold(I) dinuclear
complexes were found to have moderate antimalarial effect
(IC50 never lower than 9 μM), but less efficient than the
silver(I) counterparts. However, all gold complexes were
found to not cause hemolysis (red blood cells membrane
bursting with subsequent release of hemoglobin), in contrast
to some of the silver analogues. The second group of gold
complexes (mononuclear gold(I)) revealed an improved
Fig. 7 [Au(chloroquine)(PR3)]PF6 complexes (R = Me, Et or Ph)
prepared by Navarro et al. (adapted from [39, 65])
Fig. 8 AuI complexes based on metallocene derivatives prepared by
Bjelosevic et al. and tested as antimalarial agents (6: M = Ru, R =
CHCH3N(CH3)2; 7: M = Fe, R = CHCH3OCOCH3; 8: M = Ru, R =
CHCH3OCOCH3; 9: M = Ru, R = CHCH3NHCO(CH2)2COOH)
(adapted from [69])
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performance compared to the first group, achieving IC50
values as low as 0.33 μM for one of the compounds.
Soni and Prakash [71] described the larvicidal effect of
AuNP (synthesized using biomass derived from the
Chrysosporium tropicum fungus and HAuCl4) against Anoph-
eles stephensi larvae, a primary mosquito vector of malaria.
The exposure to AuNP solutions can lead up to 100 % mor-
tality, depending on the larval instar (developmental stage).
Although this study is not a therapy protocol for the disease
itself, the larvicidal effect obtained is significant and can lead a
better, environmentally safer and greener approach to control
this malaria vector in early stages.
Dengue
About the disease
Dengue is a febrile illness that affects infants, young children
and adults, in tropical and sub-tropical areas of the world. It is
transmitted through the bite of an Aedes mosquito, infected
with any of the four types of dengue viruses. The symptoms
include fever, with severe headache, pain behind the eyes,
muscle and joint pain, and rash. They usually appear 3 to
14 days after the insect bite. Severe dengue (plasma leakage,
strong hemorrhages, organ failure) is a potentially lethal com-
plication, affecting both children and adults. Naturally, early
clinical diagnosis can increase survival of patients [5].
Microscopy assays using nanogold
The reports on the use of microscopy in connection with
nanogold, dealing with dengue virus itself, are scarce, prob-
ably due to the viral nature of the pathogen, in contrast to the
cellular protozoans agents of the other diseases described
above. Two works, performed about two decades ago, used
immunogold applied to intracellular localization of a dengue
antigen:
Thet and Thein [72] showed the potential use of protein-
A–Au complex as a marker in the detection of dengue
antigen by immunogold labeling for light microscopy. Den-
gue 4 prototype virus H241, propagated in C6/36 mosquito
cell cultures, was used for in vitro experiments. The dengue
antigen was detected by using polystyrene beads coated
with anti-dengue IgG. The presence of dengue antigen was
shown by the formation of pink color (seen with the naked
eye) on the beads when incubated with antigen, antibody
and protein-A–Au complex. The intensity of the pink color
was found to increase with the degree of infection on the
infected coverslip cultured cells. The results obtained dem-
onstrated that the use of the protein-A–Au complex had
increased sensitivity and was able to detect antigen in the
tissue culture at the post infection as early as the first day.
Chen et al. [73] also used immunogold labeling, empha-
sizing its high sensitivity. A protein-A–Au–Ag staining was
used to detect the virus antigens in cultured dengue inocu-
lated C6/36 clone of Aedes albopictus cells and human
endothelial cells. Data from direct immunofluorescence an-
tibody (DFA) test were compared to immunogold labeling.
The study revealed that all DFA-positive specimens were
also found positive for immunogold labeling, but not vice
versa. This showed that the method using nanogold was
more sensitive than DFA.
In a recent study, Vancini et al. [74] analysed the early
events in the infection process of dengue and other Flavivi-
rus, using electron microscopy and immunogold labeling of
viral particles during cell entry. The obtained data supports
Fig. 9 Dinuclear AuI (10: n=1, R1=R2=CH3; 11: n=2, R1=R2=CH3;
12: n=2, R1=Ph, R2=H; 13: n=3, R1=Ph, R2=H), dinuclear Au
III (14:
n=1, R1=R2=CH3; 15: n=2, R1=Ph, R2=H; 16: n=3, R1=Ph, R2=H)
and mononuclear AuI (17: R = CONHPh; 18: R = quinoline; 19: R=
2,2′-bipyridine) complexes (adapted from [70]). Note: for simplicity,
the following are omitted in the figure: two PF6
− counterions for each
one of the 10–16 complexes, two Br atoms coordinated to each Au
atom for the complexes 14–16 and one Cl−, PF6
− or Br− counterion for
complexes 17–19, respectively
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the hypothesis of cells infection by a mechanism that in-
volves direct penetration of the host cell plasma membrane.
Detection methods using nanogold
Like in other biosensors described for the previously men-
tioned diseases, gold can be in the bulk (surface) form,
being a support for the sensor assembling active part, as
described by Kumbhat et al. [75] for serological diagnosis of
dengue virus infection, using surface plasmon resonance
(SPR) as analytical technique.
Gold can also be in the form of nanoparticles, as in the
following examples: Hsu and co-workers [76] described a
sensitive AuNP based inductively coupled plasma mass
spectrometry (ICP-MS) amplification and magnetic separa-
tion method for the detection of oligonucleotide virus-
specific RNA sequences. There is a sandwich-type binding
of two designed probe sequences (as illustrated in Fig. 10)
that specifically recognize the target regions. They have
attached (1) magnetic beads for easy separation and (2)
AuNP based beads for ICP-MS amplification detection.
Compared with the standard methodology (plaque assay)
for the quantification of dengue, the method described al-
lows early detection of the virus in complicated and small-
volume samples, with high specificity, good analytical sen-
sitivity, and superior time-effectiveness. The process can be
described in five main steps: (1) virus lysing, (2) incubation
with magnetic probe and washing, (3) incubation with
AuNP probe and washing, (4) releasing and dissolving
AuNP for (5) ICP-MS analysis.
Nascimento et al. [77] described the preparation and char-
acterization of a novel gold nanoparticle–polyaniline hybrid
composite (AuNpPANI, schematized in Fig. 11), containing
SH terminal groups with the ability of immobilizing dengue
serotype-specific primers (ST1, ST2 and ST3). Electrochem-
ical impedance spectroscopy (EIS) and cyclic voltammetry
(CV) were performed. The authors showed that AuNpPANI-
ST(1–3) systems (Fig. 12, left) are capable of detecting den-
gue serotypes with high specificity and reproducibility at
picomolar concentrations. The AuNpPANI-ST system
exhibited a highly selectivity response to the complementary
target of human patient’s dengue genome (Fig. 12, right).
According to the authors, this can be a step in development
of dengue serotype biosensors that are functional even in the
presence of small volumes and low concentrations of the
analyte. Even in those conditions, the CV and EIS results
showed unequivocal evidence of an existing interaction be-
tween dengue serotype-specific primers and their complemen-
tary genomic DNA targets.
The dengue IgM capture ELISA is the immunoenzymatic
system recommended by the Pan American Health Organiza-
tion and the World Health Organization for the serological
diagnosis of dengue virus infection, due to its high sensitivity,
ease of performance, and use of a single acute-phase serum
sample [78]. However, tests with the ELISA system are time-
consuming and require equipment for washing, incubation,
and reading of the results. In 2003, Vazquez et al. [78] de-
scribed the use of AuBioDOT, a multistep visual diagnostic
immunoassay that uses technology based on the IgM capture
ELISA principle. This system uses white polyethylene opaque
plates as the solid phase, colloidal gold as the marker, and
silver ion amplification. It does not require special equipment,
it is totally manually operated, and it can be performed in less
than 1 h. The application of AuBioDOT for the detection of
anti-dengue virus IgM antibodies is recommended as an alter-
native method for the diagnosis of dengue virus infection,
both for clinical diagnosis and for seroepidemiological sur-
veillance. The system is useful under field conditions and in
laboratories and requires little equipment. The AuBioDOT
IgM capture test for the detection of anti-dengue virus anti-
bodies is a multistep immunoassay that uses manual opera-
tion, visual reading, and colloidal gold-labeled conjugated
monoclonal antibodies. Colloidal AuNP were used to make
a microfluidics-based bioassay that is able to recognize spe-
cific DNA sequences via conformational change-induced
fluorescence quenching. In this method, a self-assembled
monolayer of AuNP was fabricated on the channel wall of a
microfluidic chip, and DNA probes were bonded to the mono-
layer via thiol groups. This test was applied for the detection
of the PCR product of dengue virus and results indicate that
the assay is specific for the target gene [79].
Oliveira et al. [80, 81] immobilized concanavalin A
lecitin on gold electrode using AuNP and polyvinyl butyral
and put the biosensor in contact to sera from patients
infected by dengue. Changes passible to be detected by
cyclic voltammetry and electrochemical impedance spec-
troscopy occurred.
As Foguel et al. [29] suggested for T. Cruzi detection,
Cavalcanti et al. [82] also used a gold film electrode
obtained from a recordable compact disk, but for the detec-
tion of non-structural protein 1 (NS1) of the dengue virus.
This protein is abundantly present in blood during the acute
phase of the dengue infection, in a correlation with viremia
Fig. 10 Sandwich-type binding of two probes to the target region of
the RNA virus (adapted from [76])
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levels and, consequently, can be used to early diagnostic of
the dengue hemorrhagic fever. These disposable gold elec-
trodes with anti-NS1, successfully immobilized onto gold
film surface via protein-A, present a high sensitivity (linear
response from 1 to 100 ngNS1/ml) with a relatively low
detection limit (0.33 ngNS1/ml) and selectivity in a electro-
chemical label-free detection technique. This same protein
(NS1) was also the object of the study of Muller et al. [83],
using microprojection arrays, a surface where are distributed
micrometric cones or other shapes with sharp points, capa-
ble of easy skin penetration (with more than 20,000
projections/cm2). They are usually applied to skin for the
purpose of delivering high molecular weight compounds
which cannot be delivered efficiently by other means, but
used here for directly extracting circulating protein bio-
markers from the skin. The use of gold on microprojection
arrays deals with their coating in order to allow a better
grafting (eventually with help of other small linking mole-
cules) of biomolecules like anti-NS1 antibody for NS1
capture in the subject skin epithelia extracellular fluid. The
detection of captured NS1 is made using an anti-NS1 anti-
body conjugated to HRP, using the principle described in
Fig. 2, however with a support–antibody–antigen–antibody
HRP assembling instead of the support–antigen–antibody–
antibody HRP. This test surpasses others commonly used
(like ELISA), which only accept serum/plasma samples,
thus requiring significant laboratory-based processing and
more invasive procedures for blood collecting.
There are other processes involving nanogold for dengue
research and detection, but only slightly different than the
several techniques already mentioned: Andrade et al. [84]
showed an assembly consisting of a AuNpPANI on a gold
electrode, as already shown in Fig. 12; however, this system
recognizes dengue glycoproteins instead of DNA specific
regions. Chen et al. [85] used a QCM similar to a malaria
test mentioned above, but supporting DNA dengue specific
probes and also using a signal amplification technique with
AuNP probes as those shown in Fig. 10. Oliveira et al. [86]
also used the principles described in the last paragraph, but
employed a different lecitin (from Cratylia mollis seeds) and
Fe3O4 nanoparticles.
Unfortunately, until the time this review was written, to
the best of our knowledge, there were no reports on the use
of gold for dengue therapy, being this an important area of
future research.
Conclusions
The results reported above strongly evidence the impor-
tant role of gold in tropical diseases research. In terms
of imaging, gold has high electron density which in-
creases electron scatter enabling high contrast images,
allowing a new understanding into the molecular im-
mune pathogenesis of these maladies. Immunogold tech-
niques contributed so far to understand the hemoglobin
destruction, a critical aspect in the leishmaniasis disease,
and also to the localization of an important malaria
parasite protein. In terms of dengue, the combination
of immunogold labeling and electron microscopy
allowed the detection of virus antigens, and to obtain
data supporting a mechanism of cells infection by direct
penetration of the host cell plasma membrane.
To what concerns the detection of tropical diseases, im-
portant findings have also been achieved with gold. The
research has been growing and several sensors can now
assure easier diagnosis, namely in places where the comfort
and resources of the laboratory are absent. As described
above, gold can be in the bulk (surface) form, being a
support for the sensor assembling active part, or in
nanoparticles. Au electrodes showed advantages (as they
are not influenced by oxygen dissolved in solution) for
Fig. 11 Schematic
representation of AuNpPANI
synthesis (adapted from [77])
Fig. 12 Schematic representation the AuNpPANI on a gold electrode
biosensor assembling (adapted from [77])
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Chagas disease detection, compared to Pt analogues. For
sleeping sickness, one parasite in 180 μL of blood was still
detectable in laboratory settings using gold as a colorimetric
indicator, which is a remarkable result. Promising test kits
using colloidal gold were reported for leishmaniasis and
malaria. For the former, a novel cheaper and simplified
SELEX procedure using colloidal gold has been reported.
Interesting amperometric immunosensors containing gold
were used for monitoring malaria. For dengue detection, a
fast, fully manual, visual diagnostic immunoassay compris-
ing the IgM capture ELISA principle, with colloidal gold as
marker, was reported as an alternative to conventional
ELISA systems, which are time-consuming and require a
large quantity of equipment. The use of gold on micropro-
jection arrays also surpasses ELISA. Several sensitive
AuNP-based tests have also been reported for the efficient
early detection of the dengue virus in complicated and
small-volume samples.
In terms of disease therapy, gold complexes, like the
antiarthritic drug Auranofin, showed potential antileishmanial
and antimalarial activity. Other gold complexes are promising
chemotherapeutic alternatives in the search for the cure
of several tropical diseases, namely, AuCl3(CTZ) against
Chagas disease, [Au(dppz)2]Cl3 for leishmaniasis,
[Au(PPh3)(CQ)]PF6 and other Au(I) and Au(III) com-
plexes containing CQ and NHC ligands for malaria. The
latter were found to not cause hemolysis, in contrast to
some silver analogues. AuNP also have been reported to
have interesting roles in therapy, namely against Leish-
mania promastigotes in culture medium, becoming
promising for flexible “band-aids” to be used skin le-
sions. AuNP also showed an interesting larvicidal effect
for a mosquito vector of malaria, which can be a en-
couraging approach to control the malaria vector in
early stages.
In terms of vaccines, the role of gold in biolistic immuni-
zation using a stable DNA–gold precipitate, not needing a
cold chain, is also an attractive method for vaccination against
Chagas disease in rural areas. Gold labeling showed that
monoclonal antibodies bind to glycoproteins, pointing to these
as potential candidates for a vector-directed transmission-
blocking malaria vaccine, stopping the parasite cycle in the
ookinetes–oocysts transition step.
After all that has been investigated on this topic, the
overall conclusion is that the potential of gold for stimulat-
ing research in human tropical diseases is considerable. New
results will certainly come out soon and lead to even more
practical and commercial applications, the full extent of
which has still to be envisaged.
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